vs
Mama's Creations, Inc.（MAMA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Mama's Creations, Inc.的1.5倍（$69.8M vs $47.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 1.1%，领先382.9%），Mama's Creations, Inc.同比增速更快（50.0% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 33.0%）
Mama's Creations是一家美国食品制造企业，主要生产冷藏即食、加热即食类食品，涵盖意式肉丸、香肠、意面餐食等预制菜品，产品主要供应美国本土的零售商超、大众零售商及餐饮服务合作伙伴，主打便捷高品质的家常风味食品。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MAMA vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$47.3M
营收增速更快
MAMA
高出28.8%
21.2%
净利率更高
RIGL
高出382.9%
1.1%
两年增速更快
RIGL
近两年复合增速
33.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.3M | $69.8M |
| 净利润 | $540.0K | $268.1M |
| 毛利率 | 23.6% | 91.5% |
| 营业利润率 | 1.7% | 33.2% |
| 净利率 | 1.1% | 384.0% |
| 营收同比 | 50.0% | 21.2% |
| 净利润同比 | 31.7% | 1769.2% |
| 每股收益（稀释后） | $0.01 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MAMARIGL
| Q4 25 | $47.3M | $69.8M | ||
| Q3 25 | $35.2M | $69.5M | ||
| Q2 25 | $35.3M | $101.7M | ||
| Q1 25 | $33.6M | $53.3M | ||
| Q4 24 | $31.5M | $57.6M | ||
| Q3 24 | $28.4M | $55.3M | ||
| Q2 24 | $29.8M | $36.8M | ||
| Q1 24 | $26.7M | $29.5M |
净利润MAMARIGL
| Q4 25 | $540.0K | $268.1M | ||
| Q3 25 | $1.3M | $27.9M | ||
| Q2 25 | $1.2M | $59.6M | ||
| Q1 25 | $1.6M | $11.4M | ||
| Q4 24 | $410.0K | $14.3M | ||
| Q3 24 | $1.1M | $12.4M | ||
| Q2 24 | $553.0K | $-1.0M | ||
| Q1 24 | $1.4M | $-8.2M |
毛利率MAMARIGL
| Q4 25 | 23.6% | 91.5% | ||
| Q3 25 | 24.9% | 93.2% | ||
| Q2 25 | 26.1% | 95.6% | ||
| Q1 25 | 27.0% | 91.7% | ||
| Q4 24 | 22.6% | 89.9% | ||
| Q3 24 | 24.2% | 85.5% | ||
| Q2 24 | 25.0% | 92.4% | ||
| Q1 24 | 29.3% | 93.1% |
营业利润率MAMARIGL
| Q4 25 | 1.7% | 33.2% | ||
| Q3 25 | 4.8% | 40.9% | ||
| Q2 25 | 4.5% | 60.1% | ||
| Q1 25 | 5.7% | 23.9% | ||
| Q4 24 | 1.8% | 28.9% | ||
| Q3 24 | 5.7% | 25.4% | ||
| Q2 24 | 2.6% | 1.2% | ||
| Q1 24 | 7.4% | -23.6% |
净利率MAMARIGL
| Q4 25 | 1.1% | 384.0% | ||
| Q3 25 | 3.6% | 40.2% | ||
| Q2 25 | 3.5% | 58.6% | ||
| Q1 25 | 4.8% | 21.5% | ||
| Q4 24 | 1.3% | 24.9% | ||
| Q3 24 | 4.0% | 22.5% | ||
| Q2 24 | 1.9% | -2.8% | ||
| Q1 24 | 5.3% | -27.9% |
每股收益（稀释后）MAMARIGL
| Q4 25 | $0.01 | $14.11 | ||
| Q3 25 | $0.03 | $1.46 | ||
| Q2 25 | $0.03 | $3.28 | ||
| Q1 25 | $0.04 | $0.63 | ||
| Q4 24 | $0.01 | $0.82 | ||
| Q3 24 | $0.03 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $0.03 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $49.6M | $391.5M |
| 总资产 | $84.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MAMARIGL
| Q4 25 | $18.1M | $155.0M | ||
| Q3 25 | $9.4M | $137.1M | ||
| Q2 25 | $12.0M | $108.4M | ||
| Q1 25 | $7.2M | $77.1M | ||
| Q4 24 | $9.3M | $77.3M | ||
| Q3 24 | $7.4M | $61.1M | ||
| Q2 24 | $13.0M | $49.1M | ||
| Q1 24 | $11.0M | $49.5M |
总债务MAMARIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益MAMARIGL
| Q4 25 | $49.6M | $391.5M | ||
| Q3 25 | $29.6M | $117.6M | ||
| Q2 25 | $26.4M | $81.9M | ||
| Q1 25 | $24.9M | $18.6M | ||
| Q4 24 | $23.0M | $3.3M | ||
| Q3 24 | $22.3M | $-14.6M | ||
| Q2 24 | $20.3M | $-29.9M | ||
| Q1 24 | $19.6M | $-31.7M |
总资产MAMARIGL
| Q4 25 | $84.0M | $513.6M | ||
| Q3 25 | $51.2M | $242.5M | ||
| Q2 25 | $52.7M | $206.7M | ||
| Q1 25 | $47.1M | $176.0M | ||
| Q4 24 | $47.9M | $164.0M | ||
| Q3 24 | $43.0M | $139.4M | ||
| Q2 24 | $47.2M | $128.4M | ||
| Q1 24 | $45.1M | $126.5M |
负债/权益比MAMARIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | — |
| 自由现金流率自由现金流/营收 | 7.8% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | 7.16× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $6.0M | — |
8季度趋势，按日历期对齐
经营现金流MAMARIGL
| Q4 25 | $3.9M | $22.0M | ||
| Q3 25 | $-1.7M | $24.0M | ||
| Q2 25 | $6.0M | $30.5M | ||
| Q1 25 | $-857.0K | $-893.0K | ||
| Q4 24 | $4.8M | $14.5M | ||
| Q3 24 | $-2.4M | $21.7M | ||
| Q2 24 | $3.6M | $302.0K | ||
| Q1 24 | $6.7M | $-5.0M |
自由现金流MAMARIGL
| Q4 25 | $3.7M | — | ||
| Q3 25 | $-2.2M | — | ||
| Q2 25 | $5.5M | — | ||
| Q1 25 | $-930.0K | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $6.6M | — |
自由现金流率MAMARIGL
| Q4 25 | 7.8% | — | ||
| Q3 25 | -6.2% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | -2.8% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | -14.1% | — | ||
| Q2 24 | 8.4% | — | ||
| Q1 24 | 24.8% | — |
资本支出强度MAMARIGL
| Q4 25 | 0.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 0.4% | — |
现金转化率MAMARIGL
| Q4 25 | 7.16× | 0.08× | ||
| Q3 25 | -1.31× | 0.86× | ||
| Q2 25 | 4.85× | 0.51× | ||
| Q1 25 | -0.54× | -0.08× | ||
| Q4 24 | 11.71× | 1.01× | ||
| Q3 24 | -2.10× | 1.75× | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
